A £1.5 million donation will drive joint research into antimicrobial resistance (AMR) by scientists in the UK and Japan.

The University of Warwick’s new Interdisciplinary Biomedical Research Building (IBRB) has been shortlisted for the West Midlands Building of the Year award from the Royal Institute of British Architects (RIBA).

Researchers at The University of Warwick are working to safeguard one of the world's most crucial crops – the humble onion. Amidst growing concerns over the threat posed by Fusarium Basal Rot (FBR), a team of experts from the University is embarking on a groundbreaking project, run by the British Onions Producer Agency (BOPA), aimed at saving our crops and revolutionising FBR detection.

New varieties of Britain’s favourite pulse are available for purchase this World Pulse Day (10th Feb). These UK Registered beans (URBeans) were created by Professor Eric Holub as part of his work to diversify British cooking using home-grown ingredients.

Researchers are listening to earthworms to monitor soil health, in what could be a major innovation for maintaining soil health.

Combining honey and vinegar could be an old, yet new, way of treating persistent infections.

The University of Warwick is pleased to announce the appointment of Professor Satyajit Mayor as the Leverhulme International Professor.

A new discovery by researchers at the University of Warwick could help stop bacteria being contaminated with viruses, reducing disruption and decreasing costs in industry and research.

New research will investigate whether specialised plant “train tracks” that move molecules in cells could help feed the growing population.

A new study has shown that zinc plays a key role in a hospital superbug, that doctors struggle to treat due to its resistance to antibiotics.

Like the neurons firing in human brains, bacteria use electricity to communicate and respond to environmental cues. Now, researchers have discovered a way to control this electrical signalling in bacteria, to better understand resistance to antibiotics.

A new method to aid in the development of antibiotics for tuberculosis (TB) infections has been devised.

Researchers from the University of Warwick are sharing food for thought about the humble sprout this Christmas.

A facility using gene-editing technology to improve quality, resilience and sustainability of vegetable crops has opened at the University of Warwick.

Scientists have found a promising new compound, benzyloxy-cyclopentyladenosine (BnOCPA), which has been shown to be a potent and selective pain killer in test model systems . BnOCPA is also selective in its action, and non-addictive, opening up the potential for the development of potent analgesics without side effects.

Incorporate the actions of individual farmers when forming policies to tackle livestock disease outbreaks, say researchers from the University of Warwick and University of Nottingham.

An interdisciplinary research team including four members from the University of Warwick has identified a remarkably efficient regulatory network that controls zinc accumulation in the open ocean cyanobacterium Synechococcus. The discovery is set out in a paper published today in Nature Chemical Biology.

A team of researchers led by Professor Ioannis Nezis from the School of Life Sciences has identified the molecular and cellular mechanisms that regulate selective autophagy in the fruit fly Drosophila melanogaster. While the function of these processes is increasingly understood in mammals this is one of the first studies in insects. The study of autophagy has huge potential to aid in fighting the ageing process, bacterial and viral infections and diseases including cancer, Alzheimer’s and Parkinson’s. 

A method of producing vital chemical building blocks for use in the pharmaceutical and agrochemical industries that mimics how plants manufacture them has been developed by University of Warwick scientists.

Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has in-licenced a novel, first-in-class RNA-based immunotherapy for respiratory virus infections developed at the University of Warwick.